You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

PAROMOMYCIN SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Paromomycin Sulfate patents expire, and when can generic versions of Paromomycin Sulfate launch?

Paromomycin Sulfate is a drug marketed by Heritage and Sun Pharm Inds Inc and is included in two NDAs.

The generic ingredient in PAROMOMYCIN SULFATE is paromomycin sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the paromomycin sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Paromomycin Sulfate

A generic version of PAROMOMYCIN SULFATE was approved as paromomycin sulfate by HERITAGE on December 14th, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PAROMOMYCIN SULFATE?
  • What are the global sales for PAROMOMYCIN SULFATE?
  • What is Average Wholesale Price for PAROMOMYCIN SULFATE?
Drug patent expirations by year for PAROMOMYCIN SULFATE
Recent Clinical Trials for PAROMOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Netherlands Cancer InstitutePhase 3
Kenya Medical Research InstitutePhase 3
Drugs for Neglected DiseasesPhase 3

See all PAROMOMYCIN SULFATE clinical trials

Pharmacology for PAROMOMYCIN SULFATE
Drug ClassAntiprotozoal
Medical Subject Heading (MeSH) Categories for PAROMOMYCIN SULFATE

US Patents and Regulatory Information for PAROMOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage PAROMOMYCIN SULFATE paromomycin sulfate CAPSULE;ORAL 065173-001 Dec 14, 2007 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Inc PAROMOMYCIN SULFATE paromomycin sulfate CAPSULE;ORAL 064171-001 Jun 30, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.